Full Text
Cost-Effectiveness of Cetuximab as First-Line Treatment for Metastatic Colorectal Cancer in the United States

Abstract

Authors

J.D. Ortendahl T.G. Bentley A.M. Anene A.G. Purdum B. Bolinder

Back to Volume 17, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×